0 items USD 0.00Search
Your search for "Pharma Pipeline" gave back 78919 results.
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or 鈥渟pecies鈥� of Acinetobacter and all can cause...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
The global Hearing Loss Disease Treatment Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
The increasing prevalence of hearing loss, rising age-related sensorineural degeneration, and rising awareness among people about the disease are the...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
The global market for Hearing Loss Disease Treatment Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$...
颁补迟补濒辞驳:听
MRRPB5
October 2024
Price: USD 3,950.00
The increasing prevalence of hearing loss, rising age-related sensorineural degeneration, and rising awareness among people about the disease are the...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
The increasing prevalence of hearing loss, rising age-related sensorineural degeneration, and rising awareness among people about the disease are the...
颁补迟补濒辞驳:听
MRRPB5
August 2024
Price: USD 2,900.00
The global Hearing Loss Disease Treatment Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
July 2024
Price: USD 2,900.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research鈥檚 latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals For a long time, messenger RNA (mRNA)...
颁补迟补濒辞驳:听
La Merie Publishing
June 2017
Price: USD 2,520.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
颁补迟补濒辞驳:听
Rockville Research
January 2017
Price: USD 1,200.00
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of...
颁补迟补濒辞驳:听
La Merie Publishing
January 2018
Price: USD 2,800.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
颁补迟补濒辞驳:听
CBR Pharma Insights
July 2015
Price: USD 2,995.00
鈥淒iabetic Foot Ulcer (DFU) Pipeline Analysis鈥� gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report...
颁补迟补濒辞驳:听
IQ4I
December 2018
Price: USD 3,600.00
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 225.00
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains...
颁补迟补濒辞驳:听
La Merie Publishing
October 2016
Price: USD 225.00
听
